Ameriprise’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $143K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $242K | Sell |
|
|||||
|
2023
Q3 | $429K | Sell |
|
|||||
|
2023
Q2 | $458K | Buy |
|
|||||
|
2023
Q1 | $540K | Buy |
|
|||||
|
2022
Q4 | $316K | Sell |
|
|||||
|
2022
Q3 | $466K | Sell |
|
|||||
|
2022
Q2 | $383K | Sell |
|
|||||
|
2022
Q1 | $509K | Buy |
|
|||||
|
2021
Q4 | $949K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $172K | Sell |
|
|||||
|
2021
Q1 | $391K | Sell |
|
|||||
|
2020
Q4 | $275K | Buy |
|
|||||
|
2020
Q3 | $109K | Sell |
|
|||||
|
2020
Q2 | $136K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $2.1M | Buy |
|
|||||
|
2018
Q2 | $1.1M | Buy |
|